Geode Capital Management’s Mural Oncology MURA Stock Holding History

Geode Capital Management’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-175,111	Closed	-$363K	–	4534
2025 Q3	$363K	Buy	175,111 +350	+0.2%	+$752	﹤0.01%	3727
2025 Q2	$432K	Sell	174,761 -8,624	-5%	-$20.3K	﹤0.01%	3599
2025 Q1	$231K	Buy	183,385 +2,356	+1%	+$8.59K	﹤0.01%	3793
2024 Q4	$583K	Sell	181,029 -9,027	-5%	-$31.8K	﹤0.01%	3553
2024 Q3	$595K	Buy	190,056 +4,731	+3%	+$15.4K	﹤0.01%	3536
2024 Q2	$582K	Sell	185,325 -179,696	-49%	-$662K	﹤0.01%	3511
2024 Q1	$1.79M	Buy	365,021 +8,654	+2%	+$42K	﹤0.01%	3154
2023 Q4	$2.11M	Buy	+356,367	New	+$1.43M	﹤0.01%	3083

Geode Capital Management's MURA Position: Q4 2025 in Review

Geode Capital Management sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 175,111 shares — an estimated $363K sold.

Geode Capital Management first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $2.11M in Q4 2023. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Geode Capital Management reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Geode Capital Management sold 175,111 Mural Oncology shares in Q4 2025, an estimated $363K.
Geode Capital Management first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Geode Capital Management's Mural Oncology position peaked at $2.11M in Q4 2023.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Geode Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.